Department of Obstetrics and Gynaecology

AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (2020) Banys-Paluchowski M, Stickeler E, De Boniface J, Gentilini O, Thill M, Hartmann S, Fasching P, et al. Conference contribution DETECT III und IV - Individualisierte CTC-basierte Therapie des HER2-negativen metastasierten Mammakarzinoms (2020) Friedl TWP, Schneeweiss A, Mueller , Riethdorf S, Pantel K, Taran FA, Polasik A, et al. Conference contribution DETECT V/CHEVENDO - duale HER2-zielgerichteten Therapie mit Trastuzumab und Pertuzumab plus Ribociclib in Kombination mit Chemotherapie oder endokriner Therapie bei Patientinnen mit HER2-positivem und hormonrezeptor-positivem metastasierten Mammakarzinom (2020) Friedl TWP, Polasik A, Tzschaschel M, Schochter F, De Gregorio A, Fasching P, Taran FA, et al. Conference contribution Documentation Behavior in the CANKADO eHealth-Application and Effects on observed Side Effects - An exploratory Analysis of the PreCycle-Study (2020) Schmidt M, Degenhardt T, Fasching P, Wurstlein R, Lueftner D, Kates RE, Schumacher J, et al. Conference contribution Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer. (2020) Pavanello M, Dicks E, Song H, Ariff A, Bolithon A, Intermaggio MP, Pinese M, et al. Conference contribution Endometrial Dating Method Detects Individual Maturation Sequences During the Secretory Phase (2020) Alfer J, Fattahi A, Bleisinger N, Krieg J, Behrens R, Dittrich R, Beckmann M, et al. Journal article Cervical cancer Zervixkarzinom (2020) Beckmann M, Schmidberger H Journal article Optimization of Porcine Ovarian Follicle Isolation Methods for Better Developmental Potential (2020) Fattahi A, Liverani L, Dittrich R, Hoffmann I, Boccaccini AR, Beckmann M, Bleisinger N Journal article Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) (2020) Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, et al. Journal article Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al. Journal article